LICENSE AGREEMENTLicense Agreement • August 14th, 2001 • Martha Stewart Living Omnimedia Inc • Periodicals: publishing or publishing & printing • Michigan
Contract Type FiledAugust 14th, 2001 Company Industry Jurisdiction
RECITALSSecurity Agreement • June 30th, 1997 • Sled Dogs Co • Sporting & athletic goods, nec • Minnesota
Contract Type FiledJune 30th, 1997 Company Industry Jurisdiction
EXHIBIT #3 SECOND AMENDMENT TO SETTLEMENT AGREEMENT This SECOND AMENDMENT TO SETTLEMENT AGREEMENT (the "Second Amendment") is made effective as of the 17TH day of July, 1997 by and among Frank Manchak, Jr., an individual ("Manchak"); N-Viro Energy...Settlement Agreement • July 18th, 1997 • N-Viro International Corp • Patent owners & lessors • California
Contract Type FiledJuly 18th, 1997 Company Industry Jurisdiction
FORM OF UNDERWRITING AGREEMENT ------------------------------Bionx Implants Inc • April 23rd, 1997 • Surgical & medical instruments & apparatus • New York
Company FiledApril 23rd, 1997 Industry Jurisdiction
THE SECURITY REPRESENTED BY THIS CERTIFICATE HAS BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH SALE OR DISPOSITION MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT...Nonstatutory Stock Option Agreement • November 15th, 1999 • Senesco Technologies Inc • Blank checks
Contract Type FiledNovember 15th, 1999 Company Industry
EXHIBIT 3.12 CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS DOCUMENT. CONFIDENTIAL PROVISIONS HAVE BEEN OBSCURED. BIOVATION LIMITED EXCLUSIVE LICENSE AGREEMENT This Exclusive License Agreement (this "Agreement") is made as of the 8th...Exclusive License Agreement • June 17th, 2005 • Viventia Biotech Inc. • New York
Contract Type FiledJune 17th, 2005 Company Jurisdiction
Warrant No.[ ] Number of Shares:[ ] (subject to adjustment) Date of Issuance: [ ]Senesco Technologies Inc • February 14th, 2002 • Services-commercial physical & biological research • New Jersey
Company FiledFebruary 14th, 2002 Industry Jurisdiction
CREDIT AGREEMENT among Response genetics, inc., as Borrower, SWK FUNDING LLC, as Agent, Sole Lead Arranger and Sole Bookrunner, and the financial institutions party hereto from time to time as Lenders Dated as of July 30, 2014Credit Agreement • February 2nd, 2015 • SWK Holdings Corp • Miscellaneous business credit institution • New York
Contract Type FiledFebruary 2nd, 2015 Company Industry JurisdictionThis Note has been issued pursuant to the Credit Agreement, and all of the terms, covenants and conditions of the Credit Agreement (including all Exhibits and Schedules thereto) and all other instruments evidencing or securing the indebtedness hereunder are hereby made a part of this Note and are deemed incorporated herein in full.
ASSET PURCHASE AGREEMENT by and among K-V PHARMACEUTICAL COMPANY and VIVUS, INC. dated as of March 30, 2007Asset Purchase Agreement • May 21st, 2007 • Vivus Inc • Pharmaceutical preparations • Delaware
Contract Type FiledMay 21st, 2007 Company Industry JurisdictionThis Asset Purchase Agreement (this “Agreement”) is made and entered into as of March 30, 2007, by and among K-V Pharmaceutical Company, a Delaware corporation (the “Acquiror”), and Vivus, Inc., a Delaware corporation (the “Seller”).
LICENSE AGREEMENTLicense Agreement • May 3rd, 2010 • Biosante Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Illinois
Contract Type FiledMay 3rd, 2010 Company Industry JurisdictionThis AGREEMENT (“Agreement”), dated December 3, 2008 is made by and between BioSante Pharmaceuticals, Inc., 111 Barclay Boulevard, Lincolnshire, IL 60069 (“BPA”), and Azur Pharma International II Limited, a Bermuda limited liability company, Clarendon House, 2 Church Street, Hamilton HM 11, Bermuda and such of its Affiliates as it may designate from time to time under one or more provisions of this Agreement (“Company”).
This ASSIGNMENT AND MUTUAL RELEASE AGREEMENT (thisAssignment and Mutual Release Agreement • June 22nd, 2006 • New York
Contract Type FiledJune 22nd, 2006 JurisdictionWHEREAS, Assignor and Assignee are parties to a certain License Agreement dated as of September 1, 2000 (the “License Agreement”), pursuant to which Assignor granted to Assignee an exclusive world-wide license to make, have made, use, lease, sell, offer for sale, export and import Licensed Products and to practice Licensed Processes based on certain Patent Rights, and granted Assignee certain rights with respect to Related Technology, as such capitalized terms are defined the License Agreement; and
RECITALSAssignment and Asset Transfer Agreement • November 13th, 2001 • Sonus Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
Contract Type FiledNovember 13th, 2001 Company Industry Jurisdiction
1 Exhibit 10.154 [Letterhead of Kenyon & Kenyon, Washington D.C.] February 25, 1997 VIA FACSIMILE - (419) 241-6894 ------------------------------ Peter R. Silverman, Esq. SHUMAKER, LOOP & KENDRICK, LLP 1000 Jackson Toledo, Ohio 43624-1573 Re: Manchak...N-Viro International Corp • April 15th, 1997 • Patent owners & lessors
Company FiledApril 15th, 1997 Industry
PROJECT AGREEMENTProject Agreement • April 22nd, 2024
Contract Type FiledApril 22nd, 2024THIS PROJECT AGREEMENT (the "Project Agreement"), is made as of April 23, 2024, by and between the YATES COUNTY INDUSTRIAL DEVELOPMENT AGENCY, a
1 EXHIBIT 10.9 [Letterhead of Transcend Therapeutics, Inc.] October 4, 1995 Mr. H. Walter Hauessler President, Director Patents & Technology Marketing Cornell Research Foundation, Inc. Cornell Business & Technology Park 20 Thornwood Drive, Suite 105...Transcend Therapeutics Inc • March 5th, 1997 • Biological products, (no disgnostic substances)
Company FiledMarch 5th, 1997 Industry
MACHINERY AND EQUIPMENT LOAN FUND LOAN AGREEMENTLoan Agreement • May 14th, 2007 • Power Medical Interventions, Inc.
Contract Type FiledMay 14th, 2007 CompanyTHIS LOAN AGREEMENT, MADE this 21 day of December, 2005, effective as of December 21, 2005 (the “Effective Date”) BY AND BETWEEN POWER MEDICAL INTERVENTIONS, INC., a corporation organized and existing under the laws of Delaware and having an address of 2021 Cabot Boulevard West, Langhorne, Pennsylvania 19047 (the “Borrower”) and THE COMMONWEALTH OF PENNSYLVANIA, acting by and through the DEPARTMENT OF COMMUNITY AND ECONOMIC DEVELOPMENT, having its principal place of business at Commonwealth Keystone Building, 400 North Street, Fourth Floor, Harrisburg, Pennsylvania 17120 (the “Department”).